Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study

Abstract

The results demonstrated that the novel regimen could effectively prevent the occurrence of aGVHD in haplo-PBSCT.